Healthcare Priority Setting and Rare Diseases : : What Matters When Reimbursing Orphan Drugs.
Saved in:
Superior document: | Linköping University Medical Dissertations Series ; v.1571 |
---|---|
: | |
Place / Publishing House: | Linköping : : Linkopings Universitet,, 2017. {copy}2017. |
Year of Publication: | 2017 |
Edition: | 1st ed. |
Language: | English |
Series: | Linköping University Medical Dissertations Series
|
Online Access: | |
Physical Description: | 1 online resource (98 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Opportunity Cost in Healthcare Priority Setting.
by: Siverskog, Jonathan.
Published: (2022.) -
Rare diseases and orphan products : accelerating research and development / / Committee on Accelerating Rare Diseases Research and Orphan Product Development, Board on Health Sciences Policy ; Marilyn J. Field and Thomas F. Boat, editors ; Institute of Medicine of the National Academies.
Published: (c2010.) -
Orphan lung diseases : : a clinical guide to rare lung disease / / Vincent Cottin, Jean-Francois Cordier, Luca Richeldi, editors.
Published: (2015.) -
Orphan drugs in epilepsy / / editors, Marina Nikanorova [and three others].
Published: ([2011]) -
Asking the Public : : Citizens ́Views on Priority Setting and Resource Allocation in Democratically Governed Healthcare.
by: Broqvist, Mari.
Published: (2018.)